FindTrial
Sign In

The influence of norepinephrine dosage on ventricular-arterial coupling

A Prospective Cohort Study on the Effects of Norepinephrine Dosage on Ventricular-Arterial Coupling

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500099337
Enrollment
Unknown
Registered
2025-03-21
Start date
2025-04-17
Completion date
Unknown
Last updated
2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

septic shock

Interventions

observation group:none

Sponsors

Peking University Shenzhen Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.septic shock patients; 2.Age > 18 years old; 3.norepinephrine is used for the treatment of septic shock.

Exclusion criteria

Exclusion criteria: 1.The diagnosis of septic shock has been made for >12 hours; 2.patients with concurrent acute myocardial infarction, pulmonary embolism, or a history of dilated cardiomyopathy; 3.patients receiving intra-aortic balloon pump (IABP) or ECMO treatment.

Design outcomes

Primary

MeasureTime frame
ventricular-arterial coupling;The dosage of norepinephrine;—

Secondary

MeasureTime frame
length of hospital stay, in-hospital mortality rate;—

Countries

China

Contacts

Public ContactHuang Lei

Peking University Shenzhen Hospital

hl0248@outlook.com+86 755 8392 3333

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026